Profitability Metrics

Gross Margin
65.34%
Operating Margin
15.89%
Net Margin
11.36%

Efficiency Metrics

Revenue per Expense Ratio
1.19
R&D as % of Revenue
8.45%

Earnings Quality

EBITDA Margin
25.35%
Income Tax Rate
23.42%
EPS
2.7700000000

Balance Sheet Analysis

Current Ratio
2.03
Cash Ratio
0.74
Working Capital
$11.15B
Debt to Equity
0.52
Debt to Assets
28.95%
Equity Ratio
55.81%

Cash Flow Analysis

Operating Cash Flow Ratio
20.97%
Free Cash Flow Ratio
16.07%
CapEx to Revenue
4.90%
Dividends Paid
$3.67B
Stock Buybacks
$2.14B
Total Shareholder Returns
$5.80B
Cash Position Change
-16.79%

Key Takeaways (2024 FY)

  • Increased dividend payments by 1.54%
  • Increased R&D investment by 1.45%

Detailed Growth Metrics

Core Performance

Revenue
3.64%
Net Income
-2.18%
EPS
-2.12%
Operating Income
-6.22%

Operational Efficiency

R&D Expenses
1.45%
SG&A Expenses
3.08%
Operating Cash Flow
12.39%
Free Cash Flow
13.54%

Balance Sheet Health

Assets
-1.06%
Debt
6.91%
Book Value per Share
-2.26%
Inventory
-1.44%

Shareholder Returns

Dividends per Share
1.54%
Shares Outstanding
-0.16%

Long Term Trends

3Y Revenue/Share
8.85%
5Y Revenue/Share
7.41%
3Y Dividend/Share
19.02%
5Y Dividend/Share
38.05%